Publications 2018

  1. Nastase MV, Janicova A, Roedig H, Hsieh LTH, Wygrecka M, and Schaefer L. Small leucine-rich proteoglycans in renal inflammation: two sides of the coin. J Histochem Cytochem, 66(4): 261-272, 2018

  2. Frevert CW, Felgenhauer J, Wygrecka M, Nastase MV, and Schaefer L. Danger associated molecular patterns from the extracellular matrix provide temporal control of innate immunity. J Histochem Cytochem, 66(4): 213–227, 2018

  3. Wujak L, Böttcher R, Pak O, Frey H, El Agha E, Chen Y, Schmitt S, Bellusci S, Schaefer L, Weissmann N, Fässler R, and Wygrecka M. Low Density Lipoprotein Receptor-related Protein 1 Couples β1 Integrin Activation to Degradation.Cell Mol Life Sci, 75: 1671-1685, 2018

  4. Hermann A, Wennmann DO, Gromnitza S, Edeling M, van Marck V, Sudol M, Schaefer L, Duning K, Weide T, Pavenstädt H, and Kremerskother J. WW and C2 domain-containing proteins regulate hepatic cell differentiation and tumorigenesis through the hippo signaling pathway. Hepatology, 67(4): 1546-1559, 2018

  5. Hardt S, Valek L, Zeng-Brouwers J, Wilken-Schmitz A, Schaefer L, and Tegeder I. Nephrogenic diabetes insipidus in aged progranulin deficient mice. Aging Dis. 9(5): 817-830, 2018

  6. Vutukuri R, Brunkhorst R, Kestner RI, Hansen L, Ferreiros Bouzas N, Pfeilschifter J, Devraj K, and Pfeilschifter W. Alteration of sphingolipid metabolism as a putative mechanism underlying LPS-induced BBB disruption. J Neurochem. 2017 Oct 11. doi: 10.1111/jnc.14236 (in press)

  7. Schwiebs A and Radeke H. Immunopharmacological activity of betulin in inflammation-associated carcinogenesis. Anticancer Agents Med Chem. 2017 (in press)

  8. Wujak L, Schniedera J, Schaefer L, and Wygrecka M. LRP1: a chameleon receptor of lung inflammation and repair. Matrix Biol., 68-69: 366-381, 2018

  9. Imre G and Rajalingam K. Apoptosis Inhibitor 5: Role in the inhibition of caspase-2. Cell Cycle. 17(4): 397-398, 2018

  10. Nastase MV, Zeng-Brouwers J, Wygrecka M, and Schaefer L. Targeting renal fibrosis: mechanisms and drug delivery systems. Adv Drug Deliv Rev, 129: 295-307, 2018

  11. Eresch J, Stumpf M, Koch A, Vutukuri R, Ferreirós N, Schreiber Y, Schröder K, Devraj K, Popp R, Hattenbach LO, Pfeilschifter J, and Pfeilschifter W. Sphingosine kinase 2 modulates retinal neovascularization Invest Ophthalmol Vis Sci., 59(2): 653-661, 2018

  12. Bachmann M, Pfeilschifter J, and Mühl H. A prominent role of IL-18 in acetaminophen-induced liver injury advocates its blockage for therapy of hepatic necroinflammation. Front Immunol, 9: 161. doi: 10.3389/fimmu.2018.00161. eCollection 2018

  13. Goren I, Christen U, Pfeilschifter J, and Stefan Frank. A heterogeneous Ly-6B2+ leukocyte population consists of yet undescribed iNOS-expressing cell types in murine skin wounds. Nitric Oxide, 74:23-31, 2018

  14. Nastase MV, Zeng-Brouwers J, Beckmann J, Tredup C, Christen U, Radeke HH, Wygrecka M, and Schaefer L. Biglycan, a novel trigger of Th1 and Th17 cell recruitment into the kidney. Matrix Biol 68-69: 293-317, 2018

  15. Bachmann M, Pfeilschifter J, and Mühl H. Epigenetic regulation by CpG methylation splits strong from retarded IFNγ-induced IL-18BP in epithelial versus monocytic cells. BBA-GENE REGUL MECH, 1861(3): 191-199, 2018

  16. Zakrzewicz D, Didiasova M, Krüger M, Giaimo BD, Borggrefe T, Mieth M, Hocke AC, Zakrzewicz A, Schaefer L, Preissner KT, and Wygrecka M. Protein arginine methyltransferase 5 mediates enolase-1 cell surface trafficking in human lung adenocarcinoma cells. Biochim Biophys Acta - Molecular Basis of Disease, 1864(5 Pt A): 1816-1827, 2018

  17. Wagner J, Chavakis E, Rogg E-M, Muhly-Reinholz M, Glaser SF, Guenther S, John D, Bonini F, Zeiher A, Schaefer L, Hannocks M-J, Boon RA, and Dimmeler S. A switch in laminin β2 to laminin β1 isoforms during aging enhances endothelial-mesenchymal transition. Arterioscler Thromb Vasc Biol., 38: 1170-1177, 2018

  18. Badawi A, Biyanee A, Nasrullah U, Winslow S, Schmid T, Pfeilschifter J, and Eberhardt W. Inhibition of IRES-dependent translation of caspase-2 by HuR confers chemotherapeutic drug resistance in colon carcinoma cells. Oncotarget, 2018 (in press)

  19. Didiasova M, Schaefer L, and Wygrecka M. Targeting GLI transcription factors in cancer. Molecules, 2018 (in press)

  20. Schaefer L. Decoding fibrosis: Mechanisms and translational aspects. Matrix Biol 68-69: 1-7, 2018

  21. Brunkhorst R, Pfeilschifter W, Patyna S, Büttner S, Eckes T, Trautmann S, Thomas D, Pfeilschifter J, and Koch A. Preanalytical Biases in the Measurement of Human Blood Sphingolipids. Int J Mol Sci., 19(5), 2018

  22. Patyna S, Eckes T, Büttner S, Pfeilschifter J, and Koch A. Sphingosine 1-phosphate in renal diseases: Molecular mechanisms and clinical relevance. Nieren- und Hochdruckkrankheiten, Jahrgang 47, März (137-141), 2018

  23. Roedig H, Nastase MV, Frey H, Moreth K, Zeng-Brouwers J, Poluzzi C, Hsieh LTH, Brandts C, Fulda S, Wygrecka M, and Schaefer L. Biglycan is a new high-affinity ligand for CD14 in macrophages. Matrix Biol doi:10.1016/j.matbio.2018.05.006, 2018 (in press)

  24. Huwiler A and Pfeilschifter J. Sphingolipid signaling in renal fibrosis. Matrix Biol., 68-69, 230-247, 2018

  25. Christen U, Hintermann E. Autoantibodies in Autoimmune Hepatitis: Can Epitopes Tell Us about the Etiology of the Disease? Front Immunol. 2018 Feb 16;9:163. doi: 10.3389/fimmu.2018.00163. eCollection 2018. Review.

  26. Hintermann E, Bayer M, Conti CB, Fuchs S, Fausther M, Leung PS, Aurrand-Lions M, Taubert R, Pfeilschifter JM, Friedrich-Rust M, Schuppan D, Dranoff JA, Gershwin ME, Manns MP, Imhof BA, and Christen U. Junctional adhesion molecules JAM-B and JAM-C promote autoimmune-mediated liver fibrosis in mice. J Autoimmun., 91: 83-96, 2018

  27. Christen U. Animal models of autoimmune hepatitis. Biochim Biophys Acta. 2018 May 29. pii: S0925-4439(18)30187-X. doi: 10.1016/j.bbadis.2018.05.017. [Epub ahead of print]

  28. Kwapiszewska G, Gungl A, Wilhelm J; Marsh L, Thekkekara Puthenparampil H; Sinn K, Didiasova M, Klepetko W, Kosanovic D, Schermuly RT, Wujak L, Weiss B, Schaefer L, Schneider M, Kreuter M, Olschewski A, Seeger W, Olschewski H, and Wygrecka M. Transcriptome profiling reveals the complexity of pirfenidone effects in IPF. ERJ, 2018 (in press)

  29. Rogg EM, Abplanalp WT, Bischof C, John D, Schulz MH, Krishnan J, Fischer A, Poluzzi C, Schaefer L, Bonauer A, Zeiher AM, and Dimmeler S. Analysis of cell type-specific effects of miR-92a provides novel insights into target regulation and mechanism of action. Circulation, 2018 (in press)

  30. Didiasova M, Wujak M, Schaefer L, Wygrecka M: Cellular effects of coagulation factor XII. Cell Signal, 51: 257-265. 2018

  31. Nejatian N, Trautmann S, Thomas D, Pfeilschifter J, Badenhoop K, Koch A, Penna-Martinez M. Vitamin D effects on sphingosine 1-phosphate signaling and metabolism in monocytes from type 2 diabetes patients and controls. J Steroid Biochem Mol Biol. 2018 Oct 15. pii: S0960-0760(18)30349-2. doi: 10.1016/j.jsbmb.2018.10.005. [Epub ahead of print] PubMed PMID: 30336275.

  32. Beyer S, Schwalm S, Pfeilschifter J, and Huwiler A. Renal Mesangial Cells Isolated from Sphingosine Kinase 2 Transgenic Mice Show Reduced Proliferation and are More Sensitive to Stress-Induced Apoptosis. Cell Physiol Biochem., 47: 2522-2533, 2018

 
 
Auf der rechten Seite finden Sie Links zu Publikationen aus den Jahren 2013-2015.

Zur Gesamtübersicht bitte folgenden Link verwenden: Zu den Publikationen
zu Publikationen 2018
zu Publikationen 2017
zu Publikationen 2016
 
 
Sekretariat Prof. Dr. Josef Pfeilschifter

Ute Schmidt
E-Mail:
Telefon: +49-69-6301-6951
Fax: +49-69-6301-7942/ -7420
Impressum Datenschutz
Pub Med Online
|
Universitätsklinikum